• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy".对《抗凝治疗与2019年冠状病毒病重症凝血病患者死亡率降低相关》的回复
J Thromb Haemost. 2020 Jun;18(6):1519-1520. doi: 10.1111/jth.14852. Epub 2020 May 6.
2
Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'.对《回复：抗凝治疗与2019年重症冠状病毒病凝血障碍患者死亡率降低相关》的回应
J Thromb Haemost. 2020 Jun;18(6):1520-1521. doi: 10.1111/jth.14851. Epub 2020 May 6.
3
In Response to "Coagulopathy of Coronavirus Disease 2019".回应《2019年冠状病毒病的凝血功能障碍》
Crit Care Med. 2020 Nov;48(11):e1159-e1160. doi: 10.1097/CCM.0000000000004545.
4
Thrombocytopenia and coagulation disorders due to COVID 19 infection with concomitant cardiovascular diseases requiring anti-platelet and anticoagulant therapy, which strategy?新冠病毒 19 感染导致血小板减少和凝血障碍，同时伴有需要抗血小板和抗凝治疗的心血管疾病，该采取哪种策略？
Clin Chim Acta. 2020 Sep;508:109. doi: 10.1016/j.cca.2020.05.031. Epub 2020 May 14.
5
COVID-19-associated coagulopathy.新型冠状病毒肺炎相关凝血病
Diagnosis (Berl). 2020 Nov 18;7(4):357-363. doi: 10.1515/dx-2020-0078.
6
The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.新型冠状病毒肺炎患者凝血功能障碍与抗凝药物之间的较量。
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):262-264. doi: 10.1093/ehjcvp/pvaa048.
7
Focus on coronavirus disease 2019 associated coagulopathy.关注2019冠状病毒病相关凝血病。
Chin Med J (Engl). 2020 Sep 20;133(18):2239-2241. doi: 10.1097/CM9.0000000000001019.
8
More on COVID-19 coagulopathy in Caucasian patients.关于白种人患者的新型冠状病毒肺炎凝血病的更多信息。
Br J Haematol. 2020 Jun;189(6):1060-1061. doi: 10.1111/bjh.16791. Epub 2020 May 25.
9
COVID-19 update: Covid-19-associated coagulopathy.新型冠状病毒肺炎最新情况：新型冠状病毒肺炎相关凝血病
J Thromb Thrombolysis. 2020 Jul;50(1):54-67. doi: 10.1007/s11239-020-02134-3.
10
RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19.主题：国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血功能障碍识别与管理的临时指南
J Thromb Haemost. 2020 Aug;18(8):2057-2058. doi: 10.1111/jth.14853. Epub 2020 Jul 15.

引用本文的文献

1
Management and Prevention of Cerebrovascular Accidents in SARS-CoV-2-Positive Patients Recovering from COVID-19: a Case Report and Review of Literature.新冠病毒2型（SARS-CoV-2）核酸检测阳性且已从新冠肺炎康复患者的脑血管意外管理与预防：一例病例报告及文献综述
SN Compr Clin Med. 2021;3(1):279-290. doi: 10.1007/s42399-021-00744-3. Epub 2021 Jan 16.
2
COVID-19 - Toward a comprehensive understanding of the disease.COVID-19 - 对该疾病的全面认识。
Cardiol J. 2020;27(2):99-114. doi: 10.5603/CJ.a2020.0065. Epub 2020 May 7.

本文引用的文献

1
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
2
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.血小板减少症与严重的 2019 年冠状病毒病（COVID-19）感染相关：一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
3
New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey.基于修订后的脓毒症定义的脓毒症诱导凝血功能障碍（SIC）新标准：一项全国性调查的回顾性分析
BMJ Open. 2017 Sep 27;7(9):e017046. doi: 10.1136/bmjopen-2017-017046.
4
Disseminated intravascular coagulation.弥散性血管内凝血。
Nat Rev Dis Primers. 2016 Jun 2;2:16037. doi: 10.1038/nrdp.2016.37.

Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy".

作者信息

Coto-Hernández Rubén, Fábregas Ruano María Teresa

机构信息

Unidad de Gestión Clínica de Medicina Interna, Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario Central de Asturias, Oviedo, Spain.

Medicina Interna, Hospital Universitario Puerta del Mar, Cádiz, Spain.

出版信息

J Thromb Haemost. 2020 Jun;18(6):1519-1520. doi: 10.1111/jth.14852. Epub 2020 May 6.

DOI:10.1111/jth.14852
PMID:32302445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9770774/
Abstract
摘要